ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,494Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 939

$1.01M Total Retail Price of All Prescriptions

Rank: 45 out of 939

472 Patients Receiving at Least One Drug in Part D
49%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 472 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 472 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 10,325 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 924 518 1 2
LISINOPRIL 675 420 2 3
AMLODIPINE BESYLATE 651 401 3 6
FUROSEMIDE 593 424 4 7
HYDROCODONE-ACETAMINOPHEN 551 371 S3 5 1
LEVOTHYROXINE SODIUM 499 323 6 4
METOPROLOL TARTRATE 461 286 7 10
METFORMIN HCL 382 177 8 8
POTASSIUM CHLORIDE 357 241 9 9
TRAZODONE HCL 332 162 10 26
SERTRALINE HCL 325 151 11 24
WARFARIN SODIUM 325 152 11 17
CITALOPRAM HBR 318 217 13 15
HYDROCHLOROTHIAZIDE 314 157 14 12
OMEPRAZOLE 302 139 15 5
MELOXICAM 294 194 16 14
GABAPENTIN 257 154 17 11
QUETIAPINE FUMARATE 221 150 18 69
NEXIUM 207 62 19 18
TAMSULOSIN HCL 205 117 20 27
CARVEDILOL 200 141 21 25
DONEPEZIL HCL 194 185 22 30
TRAMADOL HCL 176 88 23 16
GLIMEPIRIDE 162 83 24 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 147 70 25 23
OLANZAPINE 147 109 25 135
ZOLPIDEM TARTRATE 145 68 27 20
RISPERIDONE 141 67 28 82
AZITHROMYCIN 141 65 28 32
MIRTAZAPINE 133 108 30 56
SULFAMETHOXAZOLE-TRIMETHOPRIM 132 98 31 64
CYCLOBENZAPRINE HCL 130 34 R 32 36
DIOVAN 129 62 33 50
DIVALPROEX SODIUM 126 51 34 95
CLOZAPINE 125 68 35 203
DIGOXIN 121 64 36 45
PRAVASTATIN SODIUM 119 51 37 13
ABILIFY 117 33 38 156
CLONIDINE HCL 114 72 39 39
TRICOR 113 85 40 143
ATENOLOL 111 58 41 19
PROAIR HFA 111 33 41 41
OXYCODONE HCL 104 53 S2 43 67
SPIRIVA 104 58 43 73
METOPROLOL SUCCINATE 102 87 45 21
CLOPIDOGREL 102 77 45 28
ADVAIR DISKUS 95 49 47 60
COMBIVENT 95 42 47 120
DIOVAN HCT 94 52 49 74
FENOFIBRATE 94 61 49 83
ALLOPURINOL 91 55 51 31
CYMBALTA 89 36 52 44
MORPHINE SULFATE 82 75 S2 53 186
FLUTICASONE PROPIONATE 82 39 53 43
SYMBICORT 81 41 55 137
NOVOLOG FLEXPEN 80 39 56 295
AMITRIPTYLINE HCL 77 26 R 57 38
LEVETIRACETAM 76 18 58 170
ACTOS 73 25 59 141
TOPIRAMATE 72 17 60 154
METHYLPREDNISOLONE 72 31 60 118
NAMENDA 72 62 60 49
LYRICA 71 23 63 63
DIVALPROEX SODIUM ER 70 29 64 146
IPRATROPIUM-ALBUTEROL 70 38 64 178
PLAVIX 67 51 66 48
INSULIN SYRINGE 67 45 66 97
PHENYTOIN SODIUM EXTENDED 67 29 66 99
LANTUS 66 33 69 59
NOVOLOG 66 30 69 145
FAMOTIDINE 62 50 71 62
VENTOLIN HFA 61 30 72 80
VESICARE 59 24 73 202
BACLOFEN 55 0 74 157
PANTOPRAZOLE SODIUM 54 24 75 66
ALENDRONATE SODIUM 54 33 75 40
ESTRADIOL 54 13 R 75 79
AMOXICILLIN 53 25 78 92
METHOCARBAMOL 52 0 R 79 149
PROMETHAZINE HCL 50 25 R 80 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.